You just read:

Prometic granted orphan drug designation by FDA for Inter-Alpha-Inhibitor-Proteins for treatment of necrotizing enterocolitis (NEC)

News provided by

ProMetic Life Sciences Inc.

Feb 15, 2018, 08:41 EST